Announcements
31 December 2025
MDPI INSIGHTS: The CEO's Letter #30 - Scaling with Integrity, Highly Cited Researchers, KEMÖ Consortium, Michele Parrinello, and Best PhD Thesis Awards
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
With colleagues at MDPI headquarters in Basel, representing the people behind our global growth and shared commitment to integrity.
Scaling with Integrity: A Year of Growth, Responsibility, and Trust
When I look back on 2025, one phrase seems to sum up the year: “Scaling with integrity.” That was our watchword for 2025, and it will remain so as we move forward in to 2026.
Our journal portfolio continued to grow in 2025, reflecting the trust of a widening proportion of the scholarly community.
Today, MDPI has 355 journals indexed in Scopus and 330 in Web of Science – a testimonial to the scale at which our journals meet established external quality criteria. During the year, 45 of our journals were newly accepted into Scopus and 29 into Web of Science (this excludes transferred journals to our portfolio that were already indexed), following rigorous, independent evaluation by the world’s leading indexing bodies
Meeting external quality benchmarks
These results underline the fact that scaling responsibly is not only about expanding our catalogue, but also about meeting external quality benchmarks consistently, transparently, and at scale. Our indexing performance remains one of the strongest independent validations of MDPI’s commitment to rigor, trust, and long-term sustainability.
Over the course of 2025, we made targeted investments to ensure that the integrity of our editorial process scaled to keep pace with our growth. We strengthened our editorial governance by doubling down on our dedicated Publication Ethics department, appointing a Head of Ethics, and expanding our research integrity team by the addition of new specialists plus the creation of embedded editorial ethics roles across key journals. We also introduced new internal ethics guidelines, pre-review integrity checks, and monitoring dashboards to help teams identify potential issues and apply consistent standards across our portfolio.
Besides investing in systems and tools, we of course also invested heavily in our people and culture, delivering organisation-wide training on topics such as image integrity, AI use in publishing, and ethical oversight, while actively engaging with the wider publishing community through COPE and STM forums.
All these efforts reflect a simple principle: growth only matters if it is matched by rigor, responsibility, and trust.
Technology and AI: Supporting the editorial decision-making process
At MDPI, AI is designed to assist, not replace, editorial decision-making. It is one element in a broader system that combines people, technology, and processes to support scale responsibly.
In 2025, we continued to invest heavily in technology that supports quality rather than shortcuts. Our AI team doubled in size, ensuring that increased automation goes hand-in-hand with expertise and oversight. Proprietary AI tools such as Scholar Finder have significantly improved the precision of reviewer matching, while Ethicality has been widely adopted across editorial workflows to identify contextual signals, such as scope alignment and citation behaviour, so that human judgment can be applied where it matters most.
Partnerships: Institutional Open Access Program (IOAP) agreements and Societies
Our recent growth is also reflected in the strength of our partnerships. In 2025, we entered into more than 150 new IOAP agreements, bringing our total to 975 active agreements worldwide. This activity included the signing of our first-ever consortium agreements in North America, renewals of all major national consortia in the UK, Switzerland, Sweden, Norway, Austria, and Croatia, and the conclusion of several flat-fee agreements. At the same time, we concluded a total of 30 agreements, encompassing 24 new Society affiliations, four strategic publishing partnerships, and two journal acquisitions.
In 2025, we opened MDPI USA in Philadelphia – our latest global office, which complements our Toronto office in representing North America. MDPI USA is responsible for accelerating Open Access in the US through ongoing support of our scholars and for expanding our institutional and society partnerships.
On the other side of the globe, meanwhile, we signed an IOAP agreement in India, allowing researchers discounted Article Processing Charges (APCs), streamlined APC management for universities, and visibility into submissions, supporting India’s push for wider Open Access by offering flexible models and helping institutions meet national mandates such as Plan S.
Sustainability, sponsorships and awards
We continued to expand our sustainability efforts during 2025, hosting the 11th World Sustainability Forum, awarding CHF 125,000 in sustainability-related funding, and launching the Z-Forum on Sustainability and Innovation conference, which will officially take place in January 2026.
We also saw a record year for conference sponsorships and awards (while establishing new awards such as the Michele Parrinello Award), recognising scholars across disciplines and reinforcing our commitment to supporting the global research community at every stage of the academic journey.
Deepening our relationships
In 2025, I had the opportunity to travel more widely than ever before on MDPI business, meeting many of our stakeholders face to face and relishing the opportunity to gain a deeper understanding of their science communication needs. It was also excellent to visit a large number of MDPI offices and witness the commitment and service orientation of so many of our colleagues around the world. I shall resume my itinerary in the new year, and I look forward to many more such interactions.
Looking ahead to 2026, we will be celebrating a very significant milestone: 30 years of MDPI. From our foundation as a single Open Access journal in 1996 to the global publishing organisation we are today, our mission has remained consistent: advancing Open Access through rigorous and trustworthy scientific communication.
I would like to take this opportunity to thank all our stakeholders – authors, Editors-in-Chief, Editorial Board members, and reviewers – who have placed their trust in us during 2025. On behalf of the entire MDPI team, I look forward to deepening our relationships yet further in 2026 and celebrating 30 Years of Open Science at MDPI, something we’ve built together.
Basel, Switzerland, where MDPI was founded in 1996.
Impactful Research
621 MDPI Editors Named Highly Cited Researchers in 2025
I am pleased to share an important milestone for our editorial community and for MDPI. In late November, Clarivate announced the 2025 Highly Cited Researchers, and 621 MDPI Editorial Board Members were included among the most influential scientific contributors over the past decade!
The 621 editors come from 33 countries, representing 21 scientific disciplines, and account for nearly one in every ten Highly Cited Researchers globally. This recognition speaks to the depth of expertise across our Editorial Boards and the strength of the scientific communities that choose to collaborate with MDPI. It is important to note that while citation metrics are not in themselves a proxy for quality, they do offer one lens on sustained scientific influence.
“Our strength comes from the scientific communities who choose to work with us”
Why this is important
Having more than 600 editors recognized on this list highlights:
- The high level of expertise guiding peer review across our journals
- The global and disciplinary diversity within our Editorial Boards
- Our commitment to maintaining strong, knowledgeable, and engaged editorial oversight
Impactful science is of course shaped by broad, diverse research communities, and no single metric captures the full picture of research quality. However, this recognition does serve as meaningful, independent affirmation of the calibre of many editors who contribute to MDPI’s work.
A closer look at the recognition
Clarivate’s methodology highlights researchers whose publications rank in the top one per cent by citation count, reflecting consistent influence over the past decade. The process includes:
- Evaluation of c. 200,000 highly cited papers
- Removal of retracted publications
- Filtering of papers with unusually large authorship groups to focus on clear contributions
That so many of our editors meet these thresholds reflects the impact of the communities behind our journals.
What this means going forward
This recognition underlines the fact that our strength comes from the scientific communities who choose to work with us.
For authors, partners, and readers, it confirms that:
- MDPI journals benefit from editorial guidance grounded in active, high-impact research
- Our Editorial boards include leaders who are helping shape the future direction of their fields
- MDPI continues to attract experts who value openness, efficiency, and scientific integrity
For our internal teams, it is a reminder that the work we do every day (supporting editors, refining workflows, and improving systems) directly contributes to the trust placed in MDPI by researchers worldwide.
Thank you to all our editorial teams, publishing staff, and journal relationship specialists, and to everyone who collaborates with our Editorial Boards. Achievements like this are only possible because of your ongoing hard work, dedication, and collaboration.
From our first annual MDPI UK Summit in Manchester, bringing together over 30 Chief Editors and Editorial Board Members to discuss MDPI’s mission, achievements, and collaborations in the UK.
Inside MDPI
MDPI Launches the Michele Parrinello Award for Computational Physical Science
In case you missed it, in November, we announced the launch of the Michele Parrinello Award. This new biennial international award will recognize pioneering contributions in computational physical science. The award honours Michele Parrinello, one of the most influential scientists of the past half-century in atomistic simulations and computational materials research.
This award reflects MDPI’s long-standing commitment to recognizing scientific excellence, supporting foundational research, and inspiring the next generation of scholars across disciplines.
“Be confident that what you do is meaningful”
Honouring a transformative scientific legacy
Professor Parrinello’s work has fundamentally reshaped how scientists model matter at the atomic scale. Together with Roberto Car, he introduced ab initio molecular dynamics, widely known as the Car–Parrinello method, opening new pathways in electronic structure calculations and molecular simulations. His subsequent contributions, including the Parrinello–Rahman method and metadynamics, have become core tools across physics, chemistry, materials science, and increasingly biology.
“Do not be afraid of new things. I see it many times when we discuss a new thing that young people are scared to go against the mainstream a little bit, thinking, ‘What is going to happen to me?’ and so on. Be confident that what you do is meaningful, and do not be afraid, do not listen too much to what other people have to say.”
– Professor Michele Parrinello
A global, community-led award
The award committee is chaired by Xin-Gao Gong, Professor of Physics at Fudan University and academician of the Chinese Academy of Sciences.
The Institute for Computational Physical Sciences at Fudan University will serve as the supporting institute, reinforcing the award’s international and cross-cultural foundation.
Nominations for the first edition of the Michele Parrinello Award opened on 1 November 2025, with submissions accepted until March 2026. The award will recognize scientists whose work has advanced computational physical science across physics, chemistry, and materials research – fields increasingly central to energy, sustainability, advanced manufacturing, and technological innovation.
Why this matters for MDPI
The Michele Parrinello Award is part of the MDPI Sustainability Foundation, which supports science as a driver of long-term societal progress.
Alongside other foundation-level honours, including the World Sustainability Award, the Emerging Sustainability Leader Award, and the Tu Youyou Award, this new prize builds on our role in supporting excellence across career stages and disciplines.
MDPI journals and programs continue to recognize researchers through Best Paper Awards, Young Investigator Awards, Travel Awards, Best PhD Thesis Awards, and Outstanding Reviewer Awards. Together, these initiatives reflect a simple belief: strong scientific communities are built through recognition, trust, and sustained support.
As MDPI approaches its 30th anniversary, the launch of the Michele Parrinello Award highlights our commitment not only to publishing research but also to helping shape the future of science by celebrating those who expand its boundaries.
Coming Together for Science
KEMÖ Consortium (Austria) Extends Open Access Agreement with MDPI until 2027
I’m pleased to share that MDPI has renewed its Institutional Open Access Program (IOAP) agreement with the Austrian library consortium KEMÖ, extending our partnership through 2027.
The renewed agreement now includes 23 Austrian institutions, with the Medical University of Vienna and the University of Natural Resources and Life Sciences (BOKU) joining the partnership. Participating institutions benefit from APC discounts across MDPI’s more than 495 journals, with centralized funding options further reducing the administrative burden for researchers and libraries.
“This renewal reflects shared commitment to advancing Open Access publishing in Europe”
Austria continues to be an important and engaged research community for MDPI, with 525+ Austrian Editorial Board Members, eight Editors-in-Chief, and 15 Section Editors-in-Chief contributing to our journals.
This renewal reflects long-term trust and shared commitment to advancing Open Access publishing in Europe, and improves MDPI’s collaboration with national OA infrastructures such as the Open Access Monitor Austria. Such long-term agreements show how MDPI’s growth is increasingly built on institutional trust, collaboration, and shared commitment to Open Access.
A big thank-you to the IOAP team and everyone involved in supporting this partnership.
Closing Thoughts
Celebrating the Next Generation of Scholars: MDPI’s 2024 Best PhD Thesis Awards
One of the privileges of working in scholarly publishing is supporting the beginning of new scientific journeys. We recently announced the recipients of MDPI’s 2024 Best PhD Thesis Awards, recognizing some of the most promising emerging researchers across disciplines.
These awards do more than celebrate academic excellence. They reflect something deeper about our mission: supporting the next generation of authors and the future of Open Science.
Recognition of Excellence
This year, we made awards to 55 early-career researchers across seven fields:
- Biology and Life Sciences
- Chemistry and Materials Science
- Computer Science and Mathematics
- Engineering
- Environmental and Earth Sciences
- Medicine and Pharmacology
- Interdisciplinary ‘Other’ fields
For those of you who have completed a PhD, you’ll know first-hand that behind each number is a story of perseverance, curiosity, and sustained effort. These researchers represent institutions around the world, with thesis topics spanning:
- Brain–machine interfaces and neural engineering
- Sustainable materials and next-generation batteries
- Cancer genomics, tumour microenvironments, and immunotherapy
- AI-driven image analysis, robotics, and computational models
- Climate change monitoring and environmental risk assessment
- Regenerative medicine, biomaterials, and drug development
These dissertations are early signs of the scientific directions that will shape the coming decade.
“Our mission is about building a global community of authors”
Why this is important
Every year, millions of scholars begin their research careers with limited visibility and few platforms for sharing their work. By recognizing outstanding PhD theses, we elevate authors early in their academic journeys, build MDPI’s connection to the global research community, reinforce our commitment to quality and rigor, and highlight the depth and breadth of scholarship published across our portfolio (from biology to materials science to mathematics).
A foretaste of the future
These 55 awardees represent the next generation of researchers whose work will influence science, policy, and society in the years ahead. What we support today helps shape the scientific ecosystem of tomorrow. Our mission goes beyond publishing papers. It is about building a global community of authors who will define the next era of scientific discovery.
To explore more about MDPI Awards, including current and upcoming Best PhD Thesis Awards, please click here.
Thank you to the editors, reviewers, and teams across MDPI who make these awards possible each year.
Everything we achieved this year was made possible by the collective effort of our global teams and the trust placed in us by the scholarly community. Thank you again, and here’s to the successful continuation of our collaboration in 2026!
Chief Executive Officer
MDPI AG
25 December 2025
International Day of Epidemic Preparedness, 27 December 2025
International Day of Epidemic Preparedness is an annual observance aimed at enhancing awareness of epidemic prevention, preparedness and response, fostering a deeper recognition of the urgency to strengthen global resilience against infectious disease outbreaks, while also drawing attention to the widespread health, economic and social burdens that epidemics impose—especially on vulnerable populations and under-resourced regions. This day highlights the pivotal role that collective action plays in advancing epidemic surveillance, early warning systems, vaccine and therapeutic development, and equitable access to medical supplies and care, thereby reinforcing the imperative for robust and proactive epidemic preparedness.
|
Biology & Life Sciences |
Medicine & Pharmacology |
|
Environmental & Earth Sciences |
“Structural Insights into the SARS-CoV-2 Spike Protein and Its Implications for Antibody Resistance”
by Yuichiro Yamamoto and Kohji Noguchi
Biomolecules 2025, 15(11), 1489; https://doi.org/10.3390/biom15111489
“HSP60 and SARS-CoV-2: Les Liaisons Dangereuses”
by Adelaide Carista, Melania Ionelia Gratie, Francesco Cappello and Stefano Burgio
Biology 2025, 14(9), 1281; https://doi.org/10.3390/biology14091281
“Impact of Obesity on Immunity to the Influenza Virus: Gut Microbiota, Mechanisms, and Novel Therapeutic Strategies”
by Xiaoyue Ji and Jing Sun
Diseases 2025, 13(8), 267; https://doi.org/10.3390/diseases13080267
“Immunological Strategies for Enhancing Viral Neutralization and Protection in Antibody-Guided Vaccine Design”
by Dimitrina Miteva, Maria Kokudeva, Latchesar Tomov, Hristiana Batselova and Tsvetelina Velikova
Biologics 2025, 5(3), 21; https://doi.org/10.3390/biologics5030021
“Manifestations of Post-COVID Syndrome in Healthcare Workers in Northeast England”
by Rachael K. Raw, Jon Rees, Deborah Wilson, Sharon Gowans, Ng Cho Ee and David Chadwick
COVID 2025, 5(6), 91; https://doi.org/10.3390/covid5060091
“Aptamer Development for SARS-CoV-2 and Omicron Variants Using the Spike Protein Receptor Binding Domain as a Potential Diagnostic Tool and Therapeutic Agent”
by Prasanna V. Shekar, Anuj Kumar, Nirmitee Mulgaonkar, Samneet Kashyap, Gourav Choudhir, Sandun Fernando and Sachin Rustgi
Biomolecules 2025, 15(6), 805; https://doi.org/10.3390/biom15060805
“The Global Burden of Multidrug-Resistant Bacteria”
by Andrea Marino, Antonino Maniaci, Mario Lentini, Salvatore Ronsivalle, Giuseppe Nunnari, Salvatore Cocuzza, Federica Maria Parisi, Bruno Cacopardo, Salvatore Lavalle and Luigi La Via
Epidemiologia 2025, 6(2), 21; https://doi.org/10.3390/epidemiologia6020021
“Intricacies of Global Tuberculosis Management—EndTB-2035 on the Fence?”
by Radha Gopalaswamy and Selvakumar Subbian
J. Respir. 2025, 5(1), 4; https://doi.org/10.3390/jor5010004
“Long COVID: General Perceptions and Challenges in Diagnosis and Management”
by Katia Ozanic, Aripuana Sakurada Aranha Watanabe, Alesandra Barbosa Ferreira Machado, Vania Lucia da Silva, Vanessa Cordeiro Dias and Claudio Galuppo Diniz
COVID 2025, 5(3), 41; https://doi.org/10.3390/covid5030041
“An Increase in Aspartate Aminotransferase Can Predict Worsening Disease Severity in Japanese Patients with COVID-19”
by Kengo Matsumoto, Tsutomu Nishida, Dai Nakamatsu, Masashi Yamamoto, Koji Fukui, Osamu Morimura, Kinya Abe, Yukiyoshi Okauchi, Hiromi Iwahashi and Masami Inada
Clin. Pract. 2024, 14(4), 1601-1614; https://doi.org/10.3390/clinpract14040129
“Arbovirus Transmission in Australia from 2002 to 2017”
by Elvina Viennet, Francesca D. Frentiu, Emilie McKenna, Flavia Torres Vasconcelos, Robert L. P. Flower and Helen M. Faddy
Biology 2024, 13(7), 524; https://doi.org/10.3390/biology13070524
“Host Innate Antiviral Response to Influenza A Virus Infection: From Viral Sensing to Antagonism and Escape”
by Wenlong An, Simran Lakhina, Jessica Leong, Kartik Rawat and Matloob Husain
Pathogens 2024, 13(7), 561; https://doi.org/10.3390/pathogens13070561
“Colchicine—The Divine Medicine against COVID-19”
by Vanyo Mitev
J. Pers. Med. 2024, 14(7), 756; https://doi.org/10.3390/jpm14070756
“Towards Improved XAI-Based Epidemiological Research into the Next Potential Pandemic”
by Hamed Khalili and Maria A. Wimmer
Life 2024, 14(7), 783; https://doi.org/10.3390/life14070783
“Antimicrobial Efficacy of a Portable UV-C-Based Coating Activation Device against Candida albicans Biofilm and SARS-CoV-2 as an Additional Feature: An In Vitro Study”
by Adityakrisna Yoshi Putra Wigianto, Megumi Watanabe, Yuki Iwawaki, Takaharu Goto, Tamaki Otsuki and Tetsuo Ichikawa
Hygiene 2024, 4(1), 93-102; https://doi.org/10.3390/hygiene4010006
 |
 |
|
“Clinical and Epidemiological Study of Mycoses” |
“Genetics of Host–Pathogen Interactions” |
 |
 |
|
“Microorganisms in Neglected Tropical Diseases” |
“Ecology and Evolution of Viral Pathogens: From Wildlife to Human Infections” |
 |
 |
|
“Epidemiology of Zoonotic Virus Transmission: Pathways, Host Factors, and Public Health Strategies” |
“Advances in Coronaviruses Research: Pathogenesis, Immunity, and Antivirals” |
19 December 2025
Meet Us at the ESCMID Global 2026, 17–21 April 2026, Munich, Germany
18 December 2025
Meet Us at The World Congress of Nephrology 2026, 28–31 March 2026, Yokohama, Japan
11 December 2025
Article Layout and Template Revised for Future Volumes
9 December 2025
Meet Us at the 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka), 26–29 March 2026, Osaka, Japan
1 December 2025
World AIDS Day, 1 December 2025
1 December is World AIDS Day, the day is an opportunity for public and private partners to spread awareness about the status of the pandemic and encourage progress in HIV/AIDS prevention, treatment, and care around the world. It has become one of the most widely recognized international health days.
In recognition of this day, we recommend the following related articles, Special Issues, and journals spanning multidisciplinary fields, including clinical medicine and biology. We believe that sharing such research can raise the public’s awareness and understanding of AIDS. The aim is to strengthen scientific cooperation in response to increased awareness about HIV/AIDS and to demonstrate international solidarity in the face of the pandemic.
| Biology & Life Science | Medicine & Pharmacology | Social Science, Art and Humanities |
|
||
“Progress and Challenges in HIV-1 Vaccine Research: A Comprehensive Overview”
by Alex C. Boomgarden and Chitra Upadhyay
Vaccines 2025, 13(2), 148; https://doi.org/10.3390/vaccines13020148
“Drug-Drug Interactions Between HIV Antivirals and Concomitant Drugs in HIV Patients: What We Know and What We Need to Know”
by Emanuela De Bellis, Danilo Donnarumma, Adele Zarrella, Salvatore Maria Mazzeo, Annarita Pagano, Valentina Manzo, Ines Mazza, Francesco Sabbatino, Graziamaria Corbi, Pasquale Pagliano et al.
Pharmaceutics 2025, 17(1), 31; https://doi.org/10.3390/pharmaceutics17010031
“High Prevalence of High-Risk HPV Among People with and Without HIV: Insights into Risk Factors for Tailored Screening Approaches”
by Elena Bruzzesi, Federica Gandini, Sara Diotallevi, Riccardo Lolatto, Massimo Cernuschi, Caterina Candela, Angelo Roberto Raccagni, Flavia Passini, Andrea Marco Tamburini, Roberto Burioni et al.
Microorganisms 2024, 12(12), 2571; https://doi.org/10.3390/microorganisms12122571
“Association Between Left Ventricular Diastolic Dysfunction, Systemic Inflammation, and Gastrointestinal Symptoms in HIV-Positive Patients on Antiretroviral Therapy”
by Madalina-Ianca Suba, Bogdan Hogea, Ahmed Abu-Awwad, Voichita Elena Lazureanu, Ovidiu Rosca, Daniela Gurgus, Sorina Maria Denisa Laitin and Alina Abu-Awwad
Diseases 2024, 12(12), 313; https://doi.org/10.3390/diseases12120313
“NSC95397 Is a Novel HIV-1 Latency-Reversing Agent”
by Randilea Nichols Doyle, Vivian Yang, Yetunde I. Kayode, Robert Damoiseaux, Harry E. Taylor and Oliver I. Fregoso
Viruses 2024, 16(11), 1783; https://doi.org/10.3390/v16111783
“HIV Self-Testing: A Discussion on the Benefits, Limitations, and Implications for Public Health with a Focus on Poland”
by Aleksandra Kozieł, Igor Domański, Aleksandra Szymczak, Tomasz Dudzik, Brygida Knysz and Bartosz Szetela
Diagnostics 2024, 14(22), 2475; https://doi.org/10.3390/diagnostics14222475
“Tumor Initiation and Progression in People Living on Antiretroviral Therapies”
by Seun E. Olufemi, Daniel A. Adediran, Temitope Sobodu, Isaac O. Adejumo, Olumide F. Ajani and Elijah K. Oladipo
Biologics 2024, 4(4), 390-406; https://doi.org/10.3390/biologics4040024
“J3ExoA: A Novel Anti-HIV Immunotoxin Fusion of Anti-Gp120 J3VHH and PE38 Fragment of Pseudomonas Exotoxin A”
by Seth H. Pincus, Kun Luo, Tami Peters, James T. Gordy, Frances M. Cole, Grant Klug, Kelli Ober, Tamera K. Marcotte and Richard B. Markham
Pharmaceuticals 2025, 18(9), 1305; https://doi.org/10.3390/ph18091305
“A Memo on Factors Associated with Perception of Stigma Attached to PrEP: Evidence from the Keeping It LITE Study”
by Shahin Davoudpour, Gregory L. Phillips II, Pedro A. Serrano, Audrey L. French and Sybil G. Hosek
Sexes 2024, 5(3), 300-316; https://doi.org/10.3390/sexes5030023
“Effects of E-Cigarettes on the Lung and Systemic Metabolome in People with HIV”
by Aline Zaparte, Courtney J. Christopher, Connie Arnold, Lauren Richey, Adairre Castille, Kyle Mistretta, Christopher M. Taylor, Huiyi Lin, Steve Nelson, John P. Kirwan, John W. Apolzan, Shawn R. Campagna and David A. Welsh
Metabolites 2024, 14(8), 434; https://doi.org/10.3390/metabo14080434
“Bone Tissue Changes in Individuals Living with HIV/AIDS: The Importance of a Hierarchical Approach in Investigating Bone Fragility”
by Jelena Jadzic, Gordana Dragovic, Relja Lukic, Bozana Obradovic and Marija Djuric
J. Pers. Med. 2024, 14(8), 791; https://doi.org/10.3390/jpm14080791
“Advanced Therapies for Human Immunodeficiency Virus”
by Daniel Josef Lindegger
Med. Sci. 2024, 12(3), 33; https://doi.org/10.3390/medsci12030033
“Antiretroviral Therapy Switch in HIV-Infected Adults from a Regional HIV/AIDS Center in NE Romania”
by Isabela Ioana Loghin, Șerban Alin Rusu, Andrei Vâţă, Mihaela Cobaschi, Ion Cecan, Carmen Manciuc and Carmen Mihaela Dorobăţ
Medicina 2024, 60(6), 854; https://doi.org/10.3390/medicina60060854
“Alterations in the Gut Microbiome Composition of People Living with HIV in the Asia–Pacific Region: A Systematic Review”
by Paul Benedic U. Salvador, Patrick Josemaria d. R. Altavas, Mark Angelo S. del Rosario, Eric David B. Ornos and Leslie Michelle M. Dalmacio
Clin. Pract. 2024, 14(3), 846-861; https://doi.org/10.3390/clinpract14030066
“Systematic Review: HIV, Aging, and Housing—A North American Perspective, 2012–2023”
by Arthur S. Chaminuka, Gayle Prybutok, Victor R. Prybutok and William D. Senn
Healthcare 2024, 12(10), 992; https://doi.org/10.3390/healthcare12100992
“The Role of MicroRNAs in HIV Infection”
by Nicolas Morando, Mara Cecilia Rosenzvit, Maria A. Pando and Jens Allmer
Genes 2024, 15(5), 574; https://doi.org/10.3390/genes15050574
|
“HIV-TB Co-Infection and Pediatric Pathogen Dynamics” |
“HIV Expression in Diverse Cell Types: Mechanisms, Regulation, and Pathogenesis” |
 |
 |
|
“Research on HIV/AIDS Vaccine” |
“Gene and Cell Therapy: New Findings from Medical Research and Treatment” |
 |
 |
|
“Emerging Knowledge on Human Immunodeficiency Virus” |
“Nutrition Intervention in HIV Patients” |
 |
 |
21 November 2025
Meet Us at the 2025 ISBI Regional Conference, 3–4 December 2025, Thessaloniki, Greece
19 November 2025
MDPI Webinar | World Antimicrobial Resistance (AMR) Awareness Week 2025, 21 November 2025
In support of World Antimicrobial Resistance (AMR) Awareness Week 2025, MDPI is delighted to invite you to our special webinar, “MDPI World AMR Awareness Week Webinar 2025”. This year’s theme, “Act Now: Protect Our Present, Secure Our Future”, serves as a powerful call to immediate action against one of the most pressing global health threats—antimicrobial resistance.
Through this webinar, we aim to highlight the latest research, innovations, and cross-sector collaborations addressing AMR. We hope these discussions will inspire collective action to promote the prudent use of antimicrobials, strengthen prevention and surveillance systems, and accelerate global efforts to safeguard human, animal, and environmental health.
Thank you for joining us as we raise awareness, exchange insights, and reaffirm our shared commitment to a healthier, more resilient future.
keywords: antimicrobial resistance; antifungal resistance; food chain contamination; biofilm infections; nanomedicine; microbial genetics; mycology; public health
Date: 21 November 2025
Time: 9:00 a.m. CET | 4:00 p.m. CST (Asia)
Webinar ID: 883 6849 1341
Webinar Secretariat: journal.webinar@mdpi.com
Register now for free!
Program:
|
Speaker |
Presentation |
Time (CET) |
Time (CST Asia) |
|
|
Introduction |
9:00–9:10 a.m. |
4:00–4:10 p.m. |
|
Prof. Dr. José F. Cobo-Díaz |
Antimicrobial Resistance Spread on Food Chain: A Focus on Food Production Environments |
9:10–9:30 a.m. |
4:10–4:30 p.m. |
|
Dr. Ana Alastruey-Izquierdo |
Antifungal Resistance: Current Epidemiology and Emerging Challenges |
9:30–9:50 a.m. |
4:30–4:50 p.m. |
|
Dr. Anam Ahsan |
Nanomedicine Strategies to Overcome Biofilm-Associated Antimicrobial Resistance |
9:50–10:10 a.m. |
4:50–5:10 p.m. |
|
Prof. Dr. Michaela Lackner |
A One Health Framework for Tackling Antimycotic Resistance |
10:30–10:50 a.m. |
5:30–5:50 p.m. |
|
Dr. Elena Perrin |
From Genes to Global Health: Why Basic Research Matters in the Fight Against Antibiotic Resistance |
10:30–10:50 a.m. |
5:30–5:50 p.m. |
|
|
Q&A Session |
10:50–11:15 a.m. |
5:50–6:15 p.m. |
|
|
Closing of Webinar |
11:15–11:20 a.m. |
6:15–6:20 p.m. |
After registering, you will receive a confirmation email on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway, and we will let you know when the recording is available for viewing.
Webinar Speakers:
- Dr. José Cobo-Díaz, Department of Food Hygiene and Technology, University of Leon, Spain;
- Dr. Ana Alastruey-Izquierdo, National Microbiology Center, Carlos III Health Institute, Spain;
- Dr. Anam Ahsan, Clinical & Health Sciences / Centre for Pharmaceutical Innovation, University of South Australia, Australia;
- Prof. Dr. Michaela Lackner, Medical University of Innsbruck (MUI), Institute of Hygiene and Medical Microbiology (HMM), Austria;
- Dr. Elena Perrin, Department of Biology, University of Florence, Italy.
19 November 2025
World AMR Awareness Week—“Act Now: Protect Our Present, Secure Our Future”, 18–24 November 2025
World AMR Awareness Day 2025 draws attention to the urgent global challenge of antimicrobial resistance (AMR)—one of the greatest threats to public health, food security, and sustainable development. This year’s theme, “Act Now: Protect Our Present, Secure Our Future”, calls on the international community to take immediate, coordinated, and sustained action to preserve the effectiveness of life-saving antimicrobials. AMR affects every region of the world and every aspect of modern medicine, from surgery and cancer therapy to animal health and agriculture. Without effective antibiotics, common infections and minor injuries could once again become deadly.
To address this growing crisis, selected MDPI journals provide leading platforms for advancing research on antimicrobial resistance, surveillance, stewardship, and innovative therapeutic strategies. These include studies on new antibiotics, resistance mechanisms, diagnostic tools, infection control, and global policy frameworks. Through curated articles, Special Issues, and reprints, these journals foster cross-disciplinary collaboration among researchers, clinicians, and policymakers to combat AMR through innovation, education, and evidence-based practice.
World AMR Awareness Day serves as a powerful reminder that tackling antimicrobial resistance requires shared responsibility, sustained investment in research and innovation, and collective global action to secure a healthier, more resilient future for all.
|
Biology & Life Sciences |
Medicine & Pharmacology |
|
|
|
|
Engineering |
|
|
Date and time: 21 November 2025, 9:00 a.m. CET |
||||
|
Webinar ID: 883 6849 1341 |
||||
|
Feel free to register for this webinar here! |
||||
|
|
||||
|
Invited Speakers: |
||||
|
Dr. José F. Cobo-Díaz, |
Dr. Ana Alastruey-Izquierdo, |
Dr. Anam Ahsan, |
Prof. Dr. Michaela Lackner, |
Dr. Elena Perrin, |
|
|
|
|
|
|
“Antibacterial, Antifungal, Antiviral Activity, and Mechanisms of Action of Plant Polyphenols”
by Slavena Davidova, Angel S. Galabov and Galina Satchanska
Microorganisms 2024, 12(12), 2502; https://doi.org/10.3390/microorganisms12122502
”An Overview of the Recent Advances in Antimicrobial Resistance”
by Manuela Oliveira, Wilson Antunes, Salete Mota, Áurea Madureira-Carvalho, Ricardo Jorge Dinis-Oliveira and Diana Dias da Silva
Microorganisms 2024, 12(9), 1920; https://doi.org/10.3390/microorganisms12091920
“A Mini-Review of In Vitro Data for Candida Species, Including C. auris, Isolated during Clinical Trials of Three New Antifungals: Fosmanogepix, Ibrexafungerp, and Rezafunesgin”
by Ana Espinel-Ingroff and Nathan P. Wiederhold
J. Fungi 2024, 10(5), 362; https://doi.org/10.3390/jof10050362
“ESKAPE: Navigating the Global Battlefield for Antimicrobial Resistance and Defense in Hospitals”
by Kamna Ravi and Baljit Singh
Bacteria 2024, 3(2), 76-98; https://doi.org/10.3390/bacteria3020006
Special Issues:
|
“Fungal Infections and Antifungals” |
“Unraveling Genomic Mechanisms of Stress Tolerance and Antimicrobial Resistance in Foodborne Pathogens” |
|
|
|
“A Six-Step Protocol for Monitoring Antimicrobial Resistance Trends Using WHONET and R: Real-World Application and R Code Integration”
by Fabio Ingravalle, Antonio Vinci, Marco Ciotti, Carla Fontana, Francesca Pica, Emanuele Sebastiani, Clara Donnoli, Martino Guido Rizzo, Dario Tedesco, Silvia D’Arezzo et al.
Methods Protoc. 2025, 8(5), 115; https://doi.org/10.3390/mps8050115
“Improved Prognostic Accuracy of NEWS2 Score with Triage Data in Adults with Bacterial Sepsis: A Retrospective Cohort Study”
by Pietro Pozzessere, Roberto Lovero, Corrado Crocetta, Najada Firza, Vincenzo Brescia, Angela Pia Cazzolla, Mario Dioguardi, Francesco Testa, Marica Colella and Luigi Santacroce
Int. J. Transl. Med. 2025, 5(4), 44; https://doi.org/10.3390/ijtm5040044
“Prevalence and Antimicrobial Resistance of Typhoid Fever in Ghana: A Systematic Review and Meta-Analysis”
by Frederick Kungu, Aaron Awere-Duodu and Eric S. Donkor
Diseases 2025, 13(4), 113; https://doi.org/10.3390/diseases13040113
“Antimicrobial Resistance Patterns and Biofilm Analysis via Sonication in Intensive Care Unit Patients at a County Emergency Hospital in Romania”
by Ioana Roxana Codru, Bogdan Ioan Vintilă, Alina Simona Bereanu, Mihai Sava, Livia Mirela Popa and Victoria Birlutiu
Pharmaceuticals 2025, 18(2), 161; https://doi.org/10.3390/ph18020161
Special Issues:
|
“Hospital-Acquired Infections: Evolving Threats and Epidemiological Insights” |
“Global Partnerships in Response to Antimicrobial Resistance: From Policy to Practice” |
|
|
|
“Antimicrobial and Anti-Inflammatory Potentials of Silver Tungstate Nanoparticles, Cytotoxicity and Interference on the Activity of Antimicrobial Drugs”
by Washington de Souza Leal, Juliane Zacour Marinho, Isabela Penna Ceravolo, Lucas Leão Nascimento, Antonio Otávio de Toledo Patrocínio and Marcus Vinícius Dias-Souza
Drugs Drug Candidates 2025, 4(3), 30; https://doi.org/10.3390/ddc4030030
“Release Profile and Antibacterial Activity of Thymus sibthorpii Essential Oil-Incorporated, Optimally Stabilized Type I Collagen Hydrogels”
by Caglar Ersanli, Ioannis Skoufos, Konstantina Fotou, Athina Tzora, Yves Bayon, Despoina Mari, Eleftheria Sarafi, Konstantina Nikolaou and Dimitrios I. Zeugolis
Bioengineering 2025, 12(1), 89; https://doi.org/10.3390/bioengineering12010089
“Antimicrobial Peptides from Frogs of the Glandirana Genus”
by Frederick Harris, David A. Phoenix and Sarah R. Dennison
Biologics 2024, 4(4), 444-507; https://doi.org/10.3390/biologics4040027
“Phytochemical Composition and Antimicrobial and Antibiofilm Effect of Myrciaria cauliflora Hydroethanolic Extract against Staphylococcus aureus and Acinetobacter baumannii”
by Luciane Dias de Oliveira, Ana Luisa Monteiro Ribeiro, Sthéfani de Oliveira Dias, Geovani Moreira da Cruz, Raquel Teles de Menezes, Lara Steffany de Carvalho, Mariana Gadelho Gimenez Diamantino, Thaís Cristine Pereira, Maria Cristina Marcucci and Amjad Abu Hasna
Methods Protoc. 2024, 7(4), 60; https://doi.org/10.3390/mps7040060
“LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases”
by Surajit Bhattacharjya, Zhizhuo Zhang and Ayyalusamy Ramamoorthy
Biomolecules 2024, 14(3), 320; https://doi.org/10.3390/biom14030320
Special Issues:
|
“Development of Antibacterial Drugs to Combat Drug-Resistant Bacteria: 2nd Edition” |
“Combating Antimicrobial Resistance Spread in Food and Drinks Using Bacteriophage Technologies” |
|
|
|
|
“Targeting Biofilm-Associated Infections: Mechanistic Insights, Challenges, and Therapeutic Innovations” |
“Combating Antimicrobial Resistance: Translational Science to Clinical Practice” |
|
|
|
“Antimicrobial Resistance Gene Patterns in Traditional Montenegrin Njeguški Cheese Revealed by qPCR”
by Vesna Milanović, Giorgia Rampanti, Andrea Cantarini, Federica Cardinali, Giuseppe Paderni, Aleksandra Martinovic, Andrea Brenciani, Lucia Aquilanti, Andrea Osimani and Cristiana Garofalo
Genes 2025, 16(9), 1089; https://doi.org/10.3390/genes16091089
“Immunotherapy Potential of Animal-Sourced Probiotic Bacteria”
by Isaac Oluseun Adejumo
Biologics 2025, 5(3), 17; https://doi.org/10.3390/biologics5030017
“Screening and Genomic Profiling of Antimicrobial Bacteria Sourced from Poultry Slaughterhouse Effluents: Bacteriocin Production and Safety Evaluation”
by Nuria Peña, Irene Lafuente, Ester Sevillano, Javier Feito, Diogo Contente, Estefanía Muñoz-Atienza, Luis M. Cintas, Pablo E. Hernández and Juan Borrero
Genes 2024, 15(12), 1564; https://doi.org/10.3390/genes15121564
“The Impact of Antibiotics and Steroids on the Nasal Microbiome in Patients with Chronic Rhinosinusitis: A Systematic Review According to PICO Criteria”
by Antonella Loperfido, Carlo Cavaliere, Elona Begvarfaj, Andrea Ciofalo, Giovanni D’Erme, Marco De Vincentiis, Antonio Greco, Stefano Millarelli, Gianluca Bellocchi and Simonetta Masieri
J. Pers. Med. 2023, 13(11), 1583; https://doi.org/10.3390/jpm13111583
Special Issues:
|
“Antimicrobial Resistance (AMR) in the Food Chain: Detection Gaps and Mitigation Strategies” |
“Microbiota in Human Disease” |
|
|
|
|
|
|
|
 |
Med. Sci. Forum, 2025, ECA 2025 The 4th International Electronic Conference on Antibiotics Highlights
Click here to read the full list of papers. |
